1. Guidelines and methodological reviews concerning drug abuse liability assessment;Baster;Drug Alcohol Depend.,2003
2. Animal models of sepsis: setting the stage;Buras;Nat. Rev. Drug. Discov.,2005
3. CHMP/EWP/566/98 Rev.2/Corr, 2010.Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders. 〈http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070043.pdf〉 (accessed 25.02.15).
4. CPMP SWP Conclusions and Recommendations on the use of genetically modified animal models for carcinogenicity assessment. 〈http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003257.pdf〉 (accessed 25.02.15).